| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |